Stockhead on MSN20m
Neurizon moves to lift FDA clinical hold on motor neurone drugNeurizon Therapeutics has submitted a formal request to the US FDA for advice on pharmacokinetic studies needed to lift hold ...
Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...
Tracking targeted drug delivery is often a challenge due to limitations in the current imaging techniques. A recent study reports a breakthrough imaging technique that allows direct and highly ...
Tracking targeted drug delivery is often a challenge due to limitations in current imaging techniques. A recent study by ...
The immune system typically can ramp up the body's defenses to clear out an invading threat without issue. Glitches can happen, however, with sepsis occurring when the mustered army of cells also ...
Polypharmacology allows scientists to explore novel therapeutic purposes for existing drugs and opens new doors to treat ...
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib-an FDA-approved ...
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...
Duke pharmacology and cancer biology professor Donald McDonnell estimates his laboratory has received up to $40 million in ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...
On November 5, 2024, Adial announced the appointment of Vinay Shah as the Company’s Chief Financial Officer. Mr. Shah is an accomplished Chief Financial Officer with over 25 years of experience in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback